Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1966 5
1967 2
1968 2
1969 4
1970 2
1971 1
1972 1
1973 2
1974 4
1976 10
1977 4
1978 5
1979 5
1980 7
1981 8
1982 6
1983 6
1984 13
1985 7
1986 17
1987 13
1988 25
1989 25
1990 24
1991 35
1992 45
1993 48
1994 64
1995 50
1996 63
1997 86
1998 100
1999 136
2000 193
2001 201
2002 233
2003 299
2004 315
2005 387
2006 428
2007 456
2008 532
2009 634
2010 760
2011 869
2012 955
2013 1088
2014 1065
2015 1125
2016 1170
2017 1212
2018 1223
2019 1260
2020 1375
2021 1481
2022 1337
2023 1215
2024 1249
2025 1288
2026 958

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21,470 results

Results by year

Filters applied: . Clear all
Page 1
Extranodal natural killer/T-cell lymphoma: From fatal to curable.
Xiong J, Kwong YL, de Leval L, Qi SN, Ong CK, Gaulard P, Jaccard A, Horwitz SM, Li YX, Chen SJ, Suzuki R, Kim WS, Zhao WL. Xiong J, et al. Among authors: kim ws. CA Cancer J Clin. 2026 Jul-Aug;76(4):e70094. doi: 10.3322/caac.70094. CA Cancer J Clin. 2026. PMID: 42372027 Free PMC article. Review.
Glofitamab plus gemcitabine and oxaliplatin for relapsed/refractory DLBCL: 3-year follow-up of STARGLO.
Abramson JS, Townsend W, Fox CP, Ku M, Hertzberg M, Huang HQ, Zhang H, Yoon DH, Kim WS, Abdulhaq H, Herbaux C, Zaucha JM, Zhang QY, Chang H, Liu Y, Cheah CY, Ghesquières H, Mulvihill E, Kesavan M, Kallemeijn M, Ta R, Choeurng V, Belousov A, Relf J, Bottos A, Lundberg L, Gregory GP. Abramson JS, et al. Among authors: kim ws. Blood Adv. 2026 Aug 11;10(15):5367-5377. doi: 10.1182/bloodadvances.2026019764. Blood Adv. 2026. PMID: 42269085 Free PMC article. Clinical Trial.
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma.
Foth M, Kim W, O'Toole K, Murphy B, Justo-Garrido M, Boggaram S, Ghazi P, Brennan E, Wright MI, Shepherd T, Cortes-Sanchez E, Wang Y, Roth JA, Rees MG, Ronan MM, Jiang J, Wasko UN, Jiang A, Becker C, Deacon DC, Holmen SL, VanBrocklin MW, Hu-Lieskovan S, Kinsey CG, Russell JS, Hegde A, Garrido-Laguna I, Holderfield M, Singh M, McMahon M. Foth M, et al. Among authors: kim w. Cancer Res. 2026 Aug 14;86(16):4136-4155. doi: 10.1158/0008-5472.CAN-26-1313. Cancer Res. 2026. PMID: 42171647 Free PMC article.
Efficacy and safety of subcutaneous mosunetuzumab plus polatuzumab vedotin in patients with relapsed/refractory large B-cell lymphoma: Japan subgroup analysis of the phase III SUNMO trial.
Maruyama D, Goto H, Kumode T, Aizawa K, Fukuhara N, Westin JR, Kim WS, Mori C, Imaizumi T, Kato K. Maruyama D, et al. Among authors: kim ws. Int J Clin Oncol. 2026 Aug;31(8):1547-1556. doi: 10.1007/s10147-026-03042-x. Epub 2026 Jun 15. Int J Clin Oncol. 2026. PMID: 42298056 Free PMC article. Clinical Trial.
Cross-cohort analysis of expression and splicing quantitative trait loci in TOPMed.
Orchard P, Blackwell TW, Kachuri L, Castaldi PJ, Cho MH, Christenson SA, Durda P, Gabriel S, Hersh CP, Huntsman S, Hwang S, Joehanes R, Johnson M, Li X, Lin H, Liu CT, Liu Y, Mak ACY, Manichaikul AW, Paik DT, Saferali A, Smith JD, Taylor KD, Tracy RP, Wang J, Wang M, Weinstock JS, Weiss J, Wheeler HE, Zhou Y, Zöllner S, Wu JC, Mestroni L, Graw S, Taylor MRG, Ortega VE, Johnson WC, Gan W, Abecasis G, Nickerson DA, Gupta N, Ardlie K, Woodruff PG, Bowler RP, Meyers DA, Reiner A, Kooperberg C, Ziv E, Vasan RS, Larson MG, Cupples LA, Silverman EK, Rich SS, Heard-Costa N, Tang H, Rotter JI, Smith AV, Levy D; NHLBI TOPMed Consortium Multi-Omics Working Group32; NHLBI TOPMed Consortium32§; Aguet F, Scott LJ, Raffield LM, Parker SCJ, Abe N, Almasy L, Ament S, Anugu P, Auer P, Avramopoulos D, Balasubramanian A, Barr RG, Barwick L, Beaty T, Becker D, Becker L, Beitelshees A, Benos T, Bezerra M, Bis J, Brody J, Broeckel U, Broome J, Bunting K, Buth E, Carey V, Carty C, Casaburi R, Chaffin M, Chang C, Chang YC, Chavan S, Chen BJ, Chen WM, Choi SH, Chuang LM, Chung RH, Conomos M, Cornell E, Crandall C, Crapo J, Curtis J, Damcott C, David S, de Las Fuentes L, de Vries P, Deka R, DeMeo D, Devine … See abstract for full author list ➔ Orchard P, et al. Among authors: kim w. Science. 2026 Jul 16;393(6808):eadx2989. doi: 10.1126/science.adx2989. Epub 2026 Jul 16. Science. 2026. PMID: 42462027
Low-Dose Telmisartan/Amlodipine in Essential Hypertension: A Phase III Trial.
Ahn HS, Ahn JC, Cho JM, Lim KH, Han SH, Cho YK, Kim KH, Hong SJ, Lee CJ, Na JO, Sung KC, Choi K, Kim SY, Kim DH, Lee HC, Ihm SH, Youn JC, Choi JY, Kim SH, Kim KI, Sung JH, Pyun WB, Kim WS, Cho JS, Lee Y, Her SH, Cho EJ, Lee EM, Lee HY, Yoon YW, Lee JH, Kim W, Rhee SJ, Shin J. Ahn HS, et al. Among authors: kim w, kim ws. J Clin Hypertens (Greenwich). 2026 May;28(5):e70279. doi: 10.1111/jch.70279. J Clin Hypertens (Greenwich). 2026. PMID: 42130156 Free PMC article. Clinical Trial.
21,470 results
You have reached the last available page of results. Please see the User Guide for more information.